Elsevier

Biomaterials

Volume 73, December 2015, Pages 272-283
Biomaterials

Controlled release of cytokines using silk-biomaterials for macrophage polarization

https://doi.org/10.1016/j.biomaterials.2015.09.027Get rights and content

Abstract

Polarization of macrophages into an inflammatory (M1) or anti-inflammatory (M2) phenotype is important for clearing pathogens and wound repair, however chronic activation of either type of macrophage has been implicated in several diseases. Methods to locally control the polarization of macrophages is of great interest for biomedical implants and tissue engineering. To that end, silk protein was used to form biopolymer films that release either IFN-γ or IL-4 to control the polarization of macrophages. Modulation of the solubility of the silk films through regulation of β-sheet (crystalline) content enabled a short-term release (4–8 h) of either cytokine, with smaller amounts released out to 24 h. Altering the solubility of the films was accomplished by varying the time that the films were exposed to water vapor. The released IFN-γ or IL-4 induced polarization of THP-1 derived macrophages into the M1 or M2 phenotypes, respectively. The silk biomaterials were able to release enough IFN-γ or IL-4 to repolarize the macrophage from M1 to M2 and vice versa, demonstrating the well-established plasticity of macrophages. High β-sheet content films that are not soluble and do not release the trapped cytokines were also able to polarize macrophages that adhered to the surface through degradation of the silk protein. Chemically conjugating IFN-γ to silk films through disulfide bonds allowed for longer-term release to 10 days. The release of covalently attached IFN-γ from the films was also able to polarize M1 macrophages in vitro. Thus, the strategy described here offers new approaches to utilizing biomaterials for directing the polarization of macrophages.

Introduction

The innate immune system is the first line of defense against pathogens upon infection or wounding. Macrophages clear dead cell debris from a wound, help fight pathogens, and present pathogen-associated antigens to T-cells to activate the adaptive immune response. While macrophages are extremely important for immune defense and wound healing, chronic activation of different types of macrophages has been associated with several diseases, including atherosclerosis [1], [2], insulin resistance or metabolic syndrome [3], [4], [5], and cancer [6]. Treating these diseases by targeting macrophages systemically is not ideal, as the treatment can impair the immune system as a whole. Localized delivery of treatments for chronic macrophage activation is therefore highly desired. Furthermore, implanted devices or tissue engineered constructs can be functionally hampered by the foreign body response, which involves macrophage-derived giant cell formation and development of granulation tissue surrounding the implants. A film or thin coating on the device that can control macrophage response would be highly beneficial.

Acute inflammation occurs in a wound or at an implant site just after the deposition of fibrinogen and blood clotting. Following neutrophil infiltration monocytes are recruited to the site of the wound within the first 24 h to start clearing away dead cell debris and phagocytose bacteria that may have entered the wound [7], [8]. As the monocytes infiltrate the wound site they begin to differentiate into macrophages [9]. Once at the wound site macrophages polarize into specialized cells for different purposes. Interferon-gamma (IFN-γ) is a cytokine that activates macrophages to polarize along the “classical pathway,” which generates inflammatory macrophages, termed M1 macrophage due to the concurrent emergence of type 1 helper T-cells (Th1) [10]. M1 macrophages incite further inflammation by secreting cytokines such as interleukin-1β (IL-1β), IL-6, IL-12 and tumor necrosis factor alpha (TNF-α) [11]. Several markers of M1 macrophage differentiation have been found including C–C chemokine receptor type-7 (CCR7) [12]. These CCR7+ M1 macrophages help to defend against bacterial infections, contribute to phagocytosis of dead cells, and recruit Th1 cells to the site of the infection. Diseases associated with chronic activation of M1 macrophages include atherosclerosis [2], obesity [13], [14], and inflammatory bowel disease [15], [16].

Following the acute inflammatory phase, M2 macrophages emerge at the wound site, corresponding to the emergence of Th2 cells [17]. M2 macrophages are considered anti-inflammatory because they secrete IL-10, cytokine ligand 13 (CCL13), and transforming growth factor-beta (TGF-β), which promote tissue regeneration [18], [19]. The M2 macrophages are polarized through the “alternative pathway” by activation of the IL-4 receptor with either IL-4 or IL-13 [20]. The M2 macrophages are commonly delineated from M1 macrophages by the expression of the mannose receptor CD206 [20], as well as CD163 and CD209 [21], [22], [23], [24]. M2 macrophages have been implicated in promoting tissue regeneration and proliferation [25]. In addition, tumor associated macrophages (TAM) are believed to take on M2-like characteristics, including the M2 marker CD206, as they promote tumor progression [26], [27], [28].

One of the interesting properties of the different macrophage phenotypes is their plasticity. The ability for an M1 macrophage to become M2 or vice versa has been observed in vitro and in vivo [2], [29], [30], [31]. This leads to the possibility that macrophages can be converted using implantable biomaterials to control a specific disease. For instance, conversion of M1 macrophages that are found abundantly in atherosclerotic plaques into M2 macrophages might result in a reduction of plaque obstruction of blood flow by inducing tissue remodeling surrounding the blood vessel. Similarly, conversion of TAMs to M1 macrophages may allow them to better attack the tumors rather than aiding in their proliferation. Materials that can locally release cytokines to differentiate macrophages without systemically affecting the immune system could be very beneficial for the treatment of the macrophage associated diseases.

Recently, decellularized bone scaffolds with IL-4 bound via biotin-streptavidin interactions were used to promote vascular genesis in vivo and to control macrophage polarization in vitro [32]. That study demonstrates the potential for cytokine manipulation of host macrophages responding to implanted scaffolds. Future materials that can be coated onto any scaffold or medical device and that can release cytokines for macrophage control may have broad applications and implications for the medical industry.

Silk fibroin is a protein derived from the cocoons of the Bombyx mori silk worms and has been used for centuries as a suturing material. Silk has more recently been used as a versatile material for other biomedical purposes such as for fabricating scaffolds for cells, and therapeutics [33], [34], and for localized drug delivery into wounds [35], [36], [37]. Silk fibers can be solubilized and processed into biomaterials that have an advantage over other commonly used implantable materials because they have the ability to stabilize drugs and proteins [38], have a slow and controllable degradation rate, and the degradation products are non-toxic [39], [40].

The goal of the present study was to use thin layers of silk protein as films to modulate the release of cytokines to control macrophage responses. In the long run this approach is anticipated to help with the incorporation of tissue engineered constructs and medical device implants into the body and well as improving wound healing. Silk films were utilized in the study as they can be tailored to sustain the release of cytokines and also be processed in aqueous, ambient conditions, to preserve the functionality of the cytokines for these types of in vitro studies. The goal to control the polarization of macrophages would have value in fundamental in vitro inquiries of macrophage functions, as well as in chronic macrophage associated diseases. If successful, these approaches could be useful for treating a number of diseases from atherosclerosis to cancer by converting the M1 into M2 or vice versa.

Section snippets

Silk degumming and dissolving

Silkworm cocoons from B. mori were purchased from Tajima Shoji Co., LTD (Yokohama, Japan) and are processed into pure silk fibroin solution as previously described [41]. Briefly, cocoons are cut into small pieces and placed into boiling 0.02 mM Na2CO3 for 30 min. After boiling, the fibers are washed in deionized water and left to dry in a fume hood overnight. The next day a solution of 9.3 M LiBr is added to the silk fibers at a ratio of 1:4 weight (g) to volume (mL) and then allowed to

Solubility and cytokine release profile of silk films

Treatment of silk films with 90% methanol (MeOH) and water induces rapid β-sheet content, which causes the films to become insoluble [41]. However, solvents can cause conformational changes to proteins that lead to inactivity of the protein and thus solvents were avoided for the creation of silk films that contained the cytokines. The process of water annealing (WA) allows control of the β-sheet content of silk films, avoids brittleness [42] and avoids solvent-induced protein inactivity. The

Discussion

One goal for biomaterial and tissue engineered implants is to control the biological response, optimizing regenerative needs while reducing inflammatory pathways. Following implantation of a biomaterial, scaffold, or tissue, serum proteins will begin to adsorb to the surface allowing for immune cells to adhere and develop a response to the implant [50], [51]. Monocytes and macrophages are innate immune cells that mount part of the early response to implanted materials. Macrophages have been

Conclusions

This study investigated the ability of silk films to release cytokines and control THP-1 macrophage polarization. Silk films loaded with either IFN-γ or IL-4 were able to polarize macrophages to the M1 or M2 macrophage phenotype, respectively. Release of the cytokines from the films was found to be correlated with the solubility of the silk films, which was in turn dependant on the percentage of β-sheet content in the films. Insoluble films were also able to direct macrophage polarization after

Funding sources

We thank the NIH (P41 EB002520) for support of this research.

References (73)

  • A. Kurimoto et al.

    Keratin sponge: immobilization of lysozyme

    J. Biosci. Bioeng.

    (2003)
  • J.M. Anderson et al.

    Foreign body reaction to biomaterials

    Semin. Immunol.

    (2008)
  • J.E. Babensee et al.

    Host response to tissue engineered devices

    Adv. Drug Deliv. Rev.

    (1998)
  • S.K. Brancato et al.

    Wound macrophages as key regulators of repair

    Am. J. Pathol.

    (2011)
  • K.L. Spiller et al.

    The role of macrophage phenotype in vascularization of tissue engineering scaffolds

    Biomaterials

    (2014)
  • X. Wang et al.

    Nanolayer biomaterial coatings of silk fibroin for controlled release

    J. Control. Release Off. J. Control. Release Soc.

    (2007)
  • M. Liang et al.

    Silk fibroin immobilization on poly(ethylene terephthalate) films: comparison of two surface modification methods and their effect on mesenchymal stem cells culture

    Mater. Sci. Eng. C Mater. Biol. Appl.

    (2013)
  • C.G. Panousis et al.

    Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma

    J. Lipid Res.

    (2000)
  • V.L. King et al.

    Interleukin-4 does not influence development of hypercholesterolemia or angiotensin II-induced atherosclerotic lesions in mice

    Am. J. Pathol.

    (2007)
  • G.K. Hansson et al.

    The immune response in atherosclerosis: a double-edged sword

    Nat. Rev. Immunol.

    (2006)
  • J. Khallou-Laschet et al.

    Macrophage plasticity in experimental atherosclerosis

    PLoS One

    (2010)
  • J. Aron-Wisnewsky et al.

    Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss

    J. Clin. Endocrinol. Metab.

    (2009)
  • A. Chawla et al.

    Macrophage-mediated inflammation in metabolic disease

    Nat. Rev. Immunol.

    (2011)
  • J.I. Odegaard et al.

    Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis

    Science

    (2013)
  • M.T. Silva

    Macrophage phagocytosis of neutrophils at inflammatory/infectious foci: a cooperative mechanism in the control of infection and infectious inflammation

    J. Leukoc. Biol.

    (2011)
  • J.M. Daley et al.

    The phenotype of murine wound macrophages

    J. Leukoc. Biol.

    (2010)
  • J. Yin et al.

    Identification of an IFN-gamma-producing neutrophil early in the response to Listeria monocytogenes

    J. Immunol. Baltim. Md 1950

    (2009)
  • F.O. Martinez et al.

    The M1 and M2 paradigm of macrophage activation: time for reassessment

    F1000prime Rep.

    (2014)
  • F.O. Martinez et al.

    Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

    J. Immunol.

    (2006)
  • G.S. Hotamisligil

    Inflammation and metabolic disorders

    Nature

    (2006)
  • S.P. Weisberg et al.

    Obesity is associated with macrophage accumulation in adipose tissue

    J. Clin. Invest.

    (2003)
  • C. Abraham et al.

    Inflammatory bowel disease

    N. Engl. J. Med.

    (2009)
  • F.O. Martinez et al.

    The M1 and M2 paradigm of macrophage activation: time for reassessment

    F1000Prime Rep.

    (2014)
  • F.O. Martinez et al.

    Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

    J. Immunol. Baltim. Md 1950

    (2006)
  • S. Gordon

    Alternative activation of macrophages

    Nat. Rev. Immunol.

    (2003)
  • S. Fujisaka et al.

    Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice

    Diabetes

    (2009)
  • Cited by (106)

    • Macrophage polarization in THP-1 cell line and primary monocytes: A systematic review

      2022, Differentiation
      Citation Excerpt :

      Another interesting tissue engineering study incorporated silk protein to release interferon gamma (IFN-γ) or interleukin 4 (IL-4) at the controlled time and later assess the polarization of THP-1 into M1 and M2 macrophages according to the time of stimulants released. They successfully portrayed the plasticity of THP-1 polarization into M1 and M2 depending on the release of IFN-γ or IL-4 (Reeves et al., 2015). THP-1 derived macrophages are also used to understand nanocarrier drug delivery systems on the induction of cytokine production.

    View all citing articles on Scopus
    View full text